Plandai Biotechnology Inc (PLPL)

[Inspector Cluzo]

Emphasis of Matter
The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The
Company has incurred a deficit of approximately $26 million and has used approximately $44 million of cash due to its
operating activities in the two years ended June 30, 2014. The Company may not have adequate readily available resources to
fund operations through June 30, 2015. This raises substantial doubt about the Company's ability to continue as a going concern.
Management's plans in regard to these matters are also described in Note 1. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.
/s/ Terry L. Johnson, CPA
Casselberry, Florida
October 7, 2014